Lantern Pharma Inc. (LTRN)


Stock Price Forecast

April 18, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Lantern Pharma Inc. chart...

About the Company

We do not have any company description for Lantern Pharma Inc. at the moment.

Sector

Life Sciences

Industry

Pharmaceutical Preparations

Employees

25

Exchange

Nasdaq

$M

Total Revenue

25

Employees

$62M

Market Capitalization

-2.25

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $LTRN News

Lantern Pharma Inc (LTRN) Shares Down Despite Recent Market Volatility

7d ago, source: newsheater

The stock price of Lantern Pharma Inc (NASDAQ: LTRN) has plunged by -13.82 when compared to previous closing price of 7.74, but the company has seen a -7.62% decline in its stock price over the last ...

Lantern Pharma is harnessing the power of AI and Machine Learning to Fight Cancer

3d ago, source: PharmiWeb

This year, the United States expects to tally more than two million new cancer diagnoses— a first-ever prediction— and more than 611,000 cancer-related deaths. While the death rate from cancer is ...

The visionary biotech entrepreneur: Arun Asaithambi’s journey from PhD to NASDAQ

Opinion ago, source: Fortune India

In the landscape of the burgeoning biotechnology sector, a remarkable journey unfolds –that of Arun Asaithambi, a visionary ...

Software Segment Of Global A.I. Healthcare Billion Dollar Market Expected To Have Fastest Growth - Financial News Media

9d ago, source:

Artificial Intelligence (A.I.) has a great demand in the healthcare industry. Healthcare providers turn to tech companies for expertise in adopting AI, and naturally, demand for such expertise makes ...

Jefferies cuts Instill Bio to hold, cites drug discontinuation

7d ago, source: Seeking Alpha on MSN

Jefferies downgraded Instill Bio (NASDAQ:TIL) to hold, citing discontinuation of clinical development for the company’s drug candidate ITIL-306. The investment firm noted that with $175M in cash as of ...

Why Wang & Lee Group Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket

21h ago, source:

Wang & Lee Group posted a FY23 loss of 2 cents per share, versus a year-ago loss of 5 cents per share. The company's revenue came in at $6.83 million versus, $4.17 million in the year-ago period, ...

Lantern Theater Company to Close 30th Anniversary Season with William Shakespeare's "The Comedy of Errors"

1d ago, source: New Jersey Stage

Lantern Theater Company will close its 30th anniversary season with The Comedy of Errors, part of the company's ongoing ...

Athira Pharma Appoints Javier San Martin As New Chief Medical Officer

4d ago, source:

Biopharmaceutical company Athira Pharma, Inc. (ATHA) announced Monday the appointment of Javier San Martin as Chief Medical Officer.

Lantern Festival shuts down scam claims as Willy Wonka experience jokes roll in

8d ago, source: Indy 100 on MSN

Lantern Festival UK has shut down scam claims, adding that their sold-out London and Birmingham locations will be revealed on ...

Stock Market Highlights: Nifty violates crucial support of 20-day EMA placed at 22,370. What’s in store for D-St

4d ago, source:

Domestic benchmark equity indices dropped 1% each on Friday, dragged by financial and IT stocks, as hot US inflation data ...

Why millennials are buying in Leeds’ super suburbs

6d ago, source:

The northern city is cheap, cool and has great connections, so it’s no wonder first-time buyers are heading to the outskirts ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...